Coronary flow reserve is impaired in young men with familial hypercholesterolemia

Journal of the American College of Cardiology

Volumn 28, Issue 7, 1997, Pages 1705-1711

  Pitkänen, Olli Pekka ^c   Raitakari, Olli T ^c   Niinikoski, Harri ^c   Nuutila, Pirjo ^c   Iida, Hidehiro ^a   Voipio Pulkki, Liisa Maria ^c   Härkönen, Risto ^c   Wegelius, Uno ^c   Rönnemaa, Tapani ^c   Viikari, Jorma ^c   Knuuti, Juhani ^b  

^a RESEARCH INSTITUTE FOR BRAIN AND BLOOD VESSELS AKITA   (Japan)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIPYRIDAMOLE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY VASCULAR RESISTANCE; FAMILIAL HYPERCHOLESTEROLEMIA; HEART MUSCLE BLOOD FLOW; HEMODYNAMICS; HUMAN; HYPEREMIA; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL;

ADULT; AGE FACTORS; CHOLESTEROL; CHOLESTEROL, LDL; CORONARY CIRCULATION; CORONARY DISEASE; DIPYRIDAMOLE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE; TOMOGRAPHY, EMISSION-COMPUTED; VASCULAR RESISTANCE; VASODILATOR AGENTS;

EID: 0030463973     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(96)00376-2     Document Type: Article

References (32)

1. Stary HC. Evolution and progression of atherosclerotic lesions in coronary arteries in children and young adults. Arteriosclerosis 1989;99 Suppl I:I-19-32.
2. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992;326:242-50.
3. Haider B, Lyons M, Torres R, Oldewurtel H, Regan T. Effects of diabetes on myocardial perfusion in the atherosclerotic monkey. J Lab Clin Med 1989;113:123-32.
4. Sellke FW, Armstrong ML, Harrison DG. Endothelium-dependent vascular relaxation is abnormal in the coronary microcirculation of atherosclerotic primates. Circulation 1990;81:1586-93.
5. Ludmer PL, Selwyn AP, Shook TL, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986;95:1046-51.
6. Egashira K, Inou T, Hirooka Y, et al. Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions. J Clin Invest 1993;91:29-37.
7. Uren NG, Marraccini P, Gistri R, deSilva R, Camici P. Altered coronary vasodilator reserve and metabolism in myocardium subtended by normal arteries in patients with coronary artery disease. J Am Coll Cardiol 1993;22:650-8.
8. Dayanikli F, Grambow D, Muzik O, Mosca L, Rubenfire M, Schweiger M. Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography. Circulation 1994;90:808-17.
9. 15O. Circulation 1984;70:724-33.
10. Krivokapich J, Smith GT, Huang SC, et al. Nitrogen-13 ammonia myocardial imaging at rest and with exercise in normal volunteers: quantification of absolute myocardial perfusion with dynamic positron emission tomography. Circulation 1989;80:1328-37.
11. Hutchins GD, Schwaiger M, Rosenspire KC, Krivokapich J, Schelbert H, Kuhl DE. Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol 1990;15:1032-42.
12. Araujo LI, Lammertsma AA, Rhodes CG, et al. Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15-labeled carbon dioxide inhalation and positron emission tomography. Circulation 1991;83:875-85.
13. Leipert B, Becker BF, Gerlach E. Different endothelial mechanisms involved in coronary responses to known vasodilators. Am J Physiol 1992;262:H1676-83.
14. Mayhan WG. Endothelium-dependent responses of cerebral arterioles to adenosine 5′-diphosphate. J Vasc Res 1992;29:353-8.
15. Clark J, Crouzel C, Meyer G, Strijckmans K. Current methodology for oxygen-15 production for clinical use. Appl Radiat Isot 1987;38:597-600.
16. Crouzel C, Clark J, Brihaye C, et al. Radiochemistry automation for PET. In: Stöcklin G, Pike V, editors. Radiopharmaceuticals for Positron Emission Tomography. Netherlands: Kluwer Academic, 1993:45-90.
17. 15O and dynamic positron-emission tomography: strategy for quantification in relation to the partial-volume effect. Circulation 1988;78:104-15.
18. Iida H, Takahashi A, Tamura Y, Ono Y, Lammertsma A. Myocardial blood flow: comparison of oxygen-15-water bolus injection, slow infusion and oxygen-15-carbon dioxide slow inhalation. J Nucl Med 1995;36:78-85.
19. Iida H, Rhodes C, de Silva R, et al. Use of the left ventricular time-activity curve as a noninvasive input function in dynamic oxygen-15-water positron emission tomography. J Nucl Med 1992;33:1669-77.
20. Kadish A, Little R, Sternberg J. A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption. Clin Chem 1968;14:116-31.
21. Schifman RB, Williams J, Lichti DA. Cholesterol in high density lipoprotein: use of Mg{+2+}/dextran sulphate in its enzymatic measurement. Clin Chem 1978;24:931-7.
22. Friedewald WT, Levy R, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
23. Uren NG, Melin JA, DeBruyne B, Wijns W, Baudhuin T, Camici PG. Relation between myocardial blood flow and the severity of coronary artery stenosis. N Engl J Med 1994;330:1782-8.
24. Egashira K, Inou T, Hirooka Y, Yamada A, Urabe Y, Takeshita A. Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. N Engl J Med 1993;328:1659-64.
25. Camici PG, Chiriatti G, Lorenzoni R, Bellina RC, Gistri R, Italiani G. Coronary vasodilatation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol 1991;17:879-86.
26. Celermajer DS, Sorensen KE, Googh VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111-5.
27. Gould KL, Martucci JP, Goldberg DI, et al. Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. A potential noninvasive marker of healing coronary endothelium. Circulation 1994;89:1530-8.
28. Egashira K, Hirooka Y, Kai H, et al. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Circulation 1994;89:2519-24.
29. Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 1995;332:488-93.
30. Treasure CB, Klein JL, Weintraub WS, et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 1995;332:481-7.
31. Leung W-H, Lau C-P, Wong C-K. Beneficial effects of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolemic patients. Lancet 1993;341:1496-500.
32. Rubanyi G, Romero J, Vanhoutte P. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol 1986;240:H767-74.